NEWS DETAIL

  • Source : Press Release
  • Date : 2022-03-09
  • Companies : Sysmex Corp.

Announcement of Organizational and Personnel Changes

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces today its decision to implement organizational and personnel changes, effective April 1, 2022, as detailed below.

1. Organizational Changes 

(1) Reinforcing the Medical Affairs Function 

We will newly establish the Medical Affairs 1 Department (Hematology, Urinalysis, and Life Science), the Medical Affairs 2 Department (Hemostasis), and the Medical Affairs 3 Department (Immunochemistry) within the Medical Affairs Division to increase the speed of planning and execution of strategies for clinical evaluation, clinical performance studies, and insurance coverage for each specialized field. 

(2) Strengthening the New Business Introduction Function 

We will reinforce the new business introduction function within the Business Incubation Division. Accordingly, we will strengthen its cooperation with relevant functions with a view towards planning of the strategy and promoting the formulation for digital medicine and regenerative cell therapy. 

(3) Reinforcing the Reagent Production Function 

Following the merger of Sysmex International Reagents Co., Ltd., we will consolidate functions concerning reagent production, including strategy planning, manufacturing technology, and production management into the Reagent Production Division.

2. Personnel Changes and Appointments 

(1) Appointments of Executive Officers (Newly Appointed)

Name

New Position

Current Position

Andy Hay

Executive Officer  CEO, Sysmex America, Inc.

(2) Changes in Operating and Functional Changes of Executive Officers

Name

New Position

Current Position

Kensuke Iizuka

Senior Executive Officer
  Deputy in charge of Corporate
  Management
  Executive Vice President of
  Corporate Business Planning Div,
  Corporate Business Administration
  Div, Corporate Executive Office
Senior Executive Officer
  Deputy in charge of Corporate
  Management
  Executive Vice President of
  Corporate Business Planning Div,
  Corporate Executive Office

Kaoru Watanabe

Executive Officer
  Supervision of JEA
Executive Officer
   Supervision of JEA
Executive Vice President of JEA
Region Div.

Kinya Uchihashi

Executive Officer
  Executive Vice President of
  Reagent Production Div.
Executive Officer
  Executive Vice President of
  Reagent Production Div.
President and CEO, Sysmex
International Reagents Co., Ltd

Andy Hay

Executive Officer
CEO, Sysmex America, Inc.
CEO, Sysmex America, Inc.